Modeling prostate cancer: A perspective on transgenic mouse models

Cancer and Metastasis Reviews

Volumn 29, Issue 1, 2010, Pages 123-142

  Jeet, Varinder ^a,b   Russell, Pamela J ^a,b,c   Khatri, Aparajita ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Metastasis; PIN; Preclinical trials; Prostate cancer; SV40 antigens; Transgenic mice

Indexed keywords

2 AMINO N [4 [5 (2 PHENANTHRENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]PHENYL]ACETAMIDE; ALPHA TOCOPHEROL; ANTIANDROGEN; ANTIOXIDANT; BICALUTAMIDE; CELECOXIB; CURCUMIN; E 2869; EMODIN; FLURBIPROFEN; FLUTAMIDE; GENISTEIN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; ISOTHIOCYANIC ACID DERIVATIVE; LINOLEIC ACID; LYCOPENE; OMEGA 3 FATTY ACID; POLYPHENOL DERIVATIVE; RAPAMYCIN; RESVERATROL; RETINOL; RUTOSIDE; SELENIUM; SEOCALCITOL; STEROID RECEPTOR; TOREMIFENE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VITAMIN D; WNT PROTEIN;

ANTIANDROGEN THERAPY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BONE METASTASIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER STAGING; CASTRATION; CELL CYCLE REGULATION; CHEMOPROPHYLAXIS; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISTANT METASTASIS; DRUG EFFICACY; EMBRYONIC STEM CELL; FLOW CYTOMETRY; FUSION GENE; GENE EXPRESSION REGULATION; GENE INSERTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; GENETIC MANIPULATION; GENOMIC INSTABILITY; KNOCKOUT MOUSE; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MICRO-COMPUTED TOMOGRAPHY; MULTIPHOTON MICROSCOPY; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PATIENT MONITORING; PENETRANCE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; UNDIFFERENTIATED CARCINOMA; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; DISEASE MODELS, ANIMAL; DOGS; DRUG EVALUATION, PRECLINICAL; EVALUATION STUDIES AS TOPIC; HUMANS; IMMUNOTHERAPY; MALE; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RATS;

EID: 77349105286     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-010-9212-9     Document Type: Review

References (194)

1. A Jemal R Siegel E Ward Y Hao J Xu T Murray, et al. 2008 Cancer statistics, 2008 CA: A Cancer Journal for Clinicians 58 2 71 96
2. J Ferlay P Autier M Boniol M Heanue M Colombet P Boyle 2007 Estimates of the cancer incidence and mortality in Europe in 2006 Annals of Oncology 18 3 581 592 17287242 (Pubitemid 46359643)
3. JT Isaacs WD Heston RM Weissman DS Coffey 1978 Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT Cancer Research 38 11 Pt 2 4353 4359 698976
4. M Pollard 1998 Lobund-Wistar rat model of prostate cancer in man Prostate 37 1 1 4 9721062
5. PP Banerjee S Banerjee JM Lai JD Strandberg BR Zirkin TR Brown 1998 Age-dependent and lobe-specific spontaneous hyperplasia in the brown Norway rat prostate Biology of Reproduction 59 5 1163 1170 9780323
6. DJ Waters WA Sakr DW Hayden CM Lang L McKinney GP Murphy, et al. 1998 Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates Prostate 36 1 64 67 9650919
7. J Obradovich R Walshaw E Goullaud 1987 The influence of castration on the development of prostatic carcinoma in the dog. 43 cases (1978-1985) Journal of Veterinary Internal Medicine 1 4 183 187 3506104
8. A Rangarajan RA Weinberg 2003 Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice Nature Reviews. Cancer 3 12 952 959 14737125
9. RA DePinho 2000 The age of cancer Nature 408 6809 248 254 11089982
10. Y Sugimura GR Cunha AA Donjacour 1986 Morphogenesis of ductal networks in the mouse prostate Biology of Reproduction 34 5 961 971 3730488
11. N Hayashi Y Sugimura J Kawamura AA Donjacour GR Cunha 1991 Morphological and functional heterogeneity in the rat prostatic gland Biology of Reproduction 45 2 308 321 1786296
12. GR Cunha AA Donjacour PS Cooke S Mee RM Bigsby SJ Higgins, et al. 1987 The endocrinology and developmental biology of the prostate Endocrine Reviews 8 3 338 362 3308446
13. A Tsujimura Y Koikawa S Salm T Takao S Coetzee D Moscatelli, et al. 2002 Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis Journal of Cell Biology 157 7 1257 1265 12082083
14. SN Salm PE Burger S Coetzee K Goto D Moscatelli EL Wilson 2005 TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts Journal of Cell Biology 170 1 81 90 15983059
15. KG Leong BE Wang L Johnson WQ Gao 2008 Generation of a prostate from a single adult stem cell Nature 456 7223 804 808 18946470
16. RP Custer GC Bosma MJ Bosma 1985 Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms American Journal of Pathology 120 3 464 477 2412448
17. GN Thalmann PE Anezinis SM Chang HE Zhau EE Kim VL Hopwood, et al. 1994 Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer Cancer Research 54 10 2577 2581 8168083
18. RA Stephenson CP Dinney K Gohji NG Ordonez JJ Killion IJ Fidler 1992 Metastatic model for human prostate cancer using orthotopic implantation in nude mice Journal of the National Cancer Institute 84 12 951 957 1378502
19. WM van Weerden JC Romijn 2000 Use of nude mouse xenograft models in prostate cancer research Prostate 43 4 263 271 10861745
20. A van Bokhoven M Varella-Garcia C Korch WU Johannes EE Smith HL Miller, et al. 2003 Molecular characterization of human prostate carcinoma cell lines Prostate 57 3 205 225 14518029 (Pubitemid 37267805)
21. RE Sobel MD Sadar 2005 Cell lines used in prostate cancer research: a compendium of old and new lines-part 1 Journal of Urology 173 2 342 359 15643172
22. RE Sobel MD Sadar 2005 Cell lines used in prostate cancer research: a compendium of old and new lines-part 2 Journal of Urology 173 2 360 372 15643173
23. DG Bostwick HB Burke D Djakiew S Euling SM Ho J Landolph, et al. 2004 Human prostate cancer risk factors Cancer 101 10 Suppl 2371 2490 15495199
24. AJ Levine 1990 Tumor suppressor genes Bioessays 12 2 60 66 2140509
25. KK Frese DA Tuveson 2007 Maximizing mouse cancer models Nature Reviews. Cancer 7 9 645 658 17687385
26. OJ Becher EC Holland 2006 Genetically engineered models have advantages over xenografts for preclinical studies Cancer Research 66 7 3355 3358 16585152 discussion 3358-3359
27. TC Thompson J Southgate G Kitchener H Land 1989 Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ Cell 56 6 917 930 2538247
28. TC Thompson TL Timme SH Park G Yang C Ren 2000 Mouse prostate reconstitution model system: a series of in vivo and in vitro models for benign and malignant prostatic disease Prostate 43 4 248 254 10861743
29. TC Thompson D Kadmon TL Timme VW Merz S Egawa T Krebs, et al. 1991 Experimental oncogene induced prostate cancer Cancer Surveys 11 55 71 1726789
30. TC Thompson SH Park TL Timme C Ren JA Eastham LA Donehower, et al. 1995 Loss of p53 function leads to metastasis in ras∈+∈myc-initiated mouse prostate cancer Oncogene 10 5 869 879 7534899
31. K Williams S Fernandez X Stien K Ishii HD Love YF Lau, et al. 2005 Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype Prostate 63 4 369 384 15937962
32. A Khatri B Zhang E Doherty J Chapman K Ow H Pwint, et al. 2006 Combination of cytosine deaminase with uracil phosphoribosyl transferase leads to local and distant bystander effects against RM1 prostate cancer in mice Journal of Gene Medicine 8 9 1086 1096 16832832
33. R Martiniello-Wilks XY Wang DJ Voeks A Dane JM Shaw E Mortensen, et al. 2004 Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer Journal of Gene Medicine 6 12 1343 1357 15493036
34. D Voeks R Martiniello-Wilks V Madden K Smith E Bennetts GW Both, et al. 2002 Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models Gene Therapy 9 12 759 768 12040457
35. SJ Hall SE Mutchnik SH Chen SL Woo TC Thompson 1997 Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer International Journal of Cancer 70 2 183 187
36. SJ Hall SE Mutchnik G Yang TL Timme Y Nasu CH Bangma, et al. 1999 Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer Cancer Gene Therapy 6 1 54 63 10078964
37. K Slawin D Kadmon SH Park PT Scardino M Anzano MB Sporn, et al. 1993 Dietary fenretinide, a synthetic retinoid, decreases the tumor incidence and the tumor mass of ras∈+∈myc-induced carcinomas in the mouse prostate reconstitution model system Cancer Research 53 19 4461 4465 8402613
38. JM Adams AW Harris CA Pinkert LM Corcoran WS Alexander S Cory, et al. 1985 The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice Nature 318 6046 533 538 3906410
39. RL Brinster HY Chen A Messing T van Dyke AJ Levine RD Palmiter 1984 Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors Cell 37 2 367 379 6327063
40. D Hanahan 1989 Transgenic mice as probes into complex systems Science 246 4935 1265 1275 2686032
41. JE Green NM Greenberg CL Ashendel JC Barrett C Boone RH Getzenberg, et al. 1998 Workgroup 3: transgenic and reconstitution models of prostate cancer Prostate 36 1 59 63 9650918
42. I Ahmad OJ Sansom HY Leung 2008 Advances in mouse models of prostate cancer Expert Reviews in Molecular Medicine 10 e16 18538039
43. S Kasper 2005 Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis Journal of Cellular Biochemistry 94 2 279 297 15565647
44. C Abate-Shen MM Shen 2002 Mouse models of prostate carcinogenesis Trends in Genetics 18 5 S1 S5 12047956
45. WJ Huss LA Maddison NM Greenberg 2001 Autochthonous mouse models for prostate cancer: past, present and future Seminars in Cancer Biology 11 3 245 260 11407949
46. PA Furth 1998 SV40 rodent tumour models as paradigms of human disease: transgenic mouse models Developments in Biological Standardization 94 281 287 9776248
47. NM Greenberg F DeMayo MJ Finegold D Medina WD Tilley JO Aspinall, et al. 1995 Prostate cancer in a transgenic mouse Proceedings of the National Academy of Sciences of the United States of America 92 8 3439 3443 7724580
48. JR Gingrich RJ Barrios RA Morton BF Boyce FJ DeMayo MJ Finegold, et al. 1996 Metastatic prostate cancer in a transgenic mouse Cancer Research 56 18 4096 4102 8797572
49. SM Dilworth 1990 Cell alterations induced by the large T-antigens of SV40 and polyoma virus Seminars in Cancer Biology 1 6 407 414 1966492
50. E Sontag S Fedorov C Kamibayashi D Robbins M Cobb M Mumby 1993 The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation Cell 75 5 887 897 8252625
51. JR Gingrich RJ Barrios BA Foster NM Greenberg 1999 Pathologic progression of autochthonous prostate cancer in the TRAMP model Prostate Cancer and Prostatic Diseases 2 2 70 75 12496841
52. JR Gingrich RJ Barrios MW Kattan HS Nahm MJ Finegold NM Greenberg 1997 Androgen-independent prostate cancer progression in the TRAMP model Cancer Research 57 21 4687 4691 9354422
53. G Han BA Foster S Mistry G Buchanan JM Harris WD Tilley, et al. 2001 Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer Journal of Biological Chemistry 276 14 11204 11213 11063747
54. KM Haram HJ Peltier B Lu M Bhasin HH Otu B Choy, et al. 2008 Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy Prostate 68 14 1517 1530 18668517
55. BA Foster JR Gingrich ED Kwon C Madias NM Greenberg 1997 Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model Cancer Research 57 16 3325 3330 9269988
56. V Jeet K Ow E Doherty B Curley PJ Russell A Khatri 2008 Broadening of transgenic adenocarcinoma of the mouse prostate (TRAMP) model to represent late stage androgen depletion independent cancer Prostate 68 5 548 562 18247402
57. WJ Huss CF Hanrahan RJ Barrios JW Simons NM Greenberg 2001 Angiogenesis and prostate cancer: identification of a molecular progression switch Cancer Research 61 6 2736 2743 11289156
58. ED Kwon AA Hurwitz BA Foster C Madias AL Feldhaus NM Greenberg, et al. 1997 Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer Proceedings of the National Academy of Sciences of the United States of America 94 15 8099 8103 9223321
59. DJ Voeks R Martiniello-Wilks PJ Russell 2002 Derivation of MPR and TRAMP models of prostate cancer and prostate cancer metastasis for evaluation of therapeutic strategies Urologic Oncology 7 3 111 118 12474544
60. S Kasper PC Sheppard Y Yan N Pettigrew AD Borowsky GS Prins, et al. 1998 Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer Laboratory Investigation 78 3 319 333 9520945
61. N Masumori TZ Thomas P Chaurand T Case M Paul S Kasper, et al. 2001 A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential Cancer Research 61 5 2239 2249 11280793
62. V Venkateswaran NE Fleshner LM Sugar LH Klotz 2004 Antioxidants block prostate cancer in lady transgenic mice Cancer Research 64 16 5891 5896 15313934
63. H Bonkhoff 1998 Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status Prostate. Supplement 8 18 22 9690659 (Pubitemid 28347991)
64. H Bonkhoff T Fixemer 2004 Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype Urologe A 43 7 836 842 15048555
65. IG Maroulakou M Anver L Garrett JE Green 1994 Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene Proceedings of the National Academy of Sciences of the United States of America 91 23 11236 11240 7972041
66. MA Shibata CL Jorcyk ML Liu K Yoshidome LG Gold JE Green 1998 The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer Toxicologic Pathology 26 1 177 182 9502400
67. EM Garabedian PA Humphrey JI Gordon 1998 A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells Proceedings of the National Academy of Sciences of the United States of America 95 26 15382 15387 9860977
68. C Perez-Stable NH Altman PP Mehta LJ Deftos BA Roos 1997 Prostate cancer progression, metastasis, and gene expression in transgenic mice Cancer Research 57 5 900 906 9041192
69. MY Gabril W Duan G Wu M Moussa JI Izawa CJ Panchal, et al. 2005 A novel knock-in prostate cancer model demonstrates biology similar to that of human prostate cancer and suitable for preclinical studies Molecular Therapy 11 3 348 362 15727931
70. IV Huizen G Wu M Moussa JL Chin A Fenster JC Lacefield, et al. 2005 Establishment of a serum tumor marker for preclinical trials of mouse prostate cancer models Clinical Cancer Research 11 21 7911 7919 16278416
71. B Jasani A Cristaudo SA Emri AF Gazdar A Gibbs B Krynska, et al. 2001 Association of SV40 with human tumours Seminars in Cancer Biology 11 1 49 61 11243899
72. J Qian RB Jenkins DG Bostwick 1997 Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization Modern Pathology 10 11 1113 1119 9388062 (Pubitemid 27521289)
73. RB Jenkins J Qian MM Lieber DG Bostwick 1997 Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization Cancer Research 57 3 524 531 9012485
74. X Zhang C Lee PY Ng M Rubin A Shabsigh R Buttyan 2000 Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein Prostate 43 4 278 285 10861747
75. K Ellwood-Yen TG Graeber J Wongvipat ML Iruela-Arispe J Zhang R Matusik, et al. 2003 Myc-driven murine prostate cancer shares molecular features with human prostate tumors Cancer Cell 4 3 223 238 14522256
76. M Stanbrough I Leav PW Kwan GJ Bubley SP Balk 2001 Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium Proceedings of the National Academy of Sciences of the United States of America 98 19 10823 10828 11535819
77. JF Couse S Curtis Hewitt KS Korach 2000 Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues Journal of Steroid Biochemistry and Molecular Biology 74 5 287 296 11162937
78. J Huang WC Powell AC Khodavirdi J Wu T Makita RD Cardiff, et al. 2002 Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium Cancer Research 62 16 4812 4819 12183441
79. D Lohnes P Kastner A Dierich M Mark M LeMeur P Chambon 1993 Function of retinoic acid receptor gamma in the mouse Cell 73 4 643 658 8388780
80. M Ozen D Giri F Ropiquet A Mansukhani M Ittmann 2001 Role of fibroblast growth factor receptor signaling in prostate cancer cell survival Journal of the National Cancer Institute 93 23 1783 1790 11734594
81. BA Foster PJ Kaplan NM Greenberg 1999 Characterization of the FGF axis and identification of a novel FGFR1iiic isoform during prostate cancer progression in the TRAMP model Prostate Cancer and Prostatic Diseases 2 2 76 82 12496842
82. PJ Russell S Bennett P Stricker 1998 Growth factor involvement in progression of prostate cancer Clinical Chemistry 44 4 705 723 9554481
83. GR Cunha ET Alarid T Turner AA Donjacour EL Boutin BA Foster 1992 Normal and abnormal development of the male urogenital tract. Role of androgens, mesenchymal-epithelial interactions, and growth factors Journal of Andrology 13 6 465 475 1293128
84. N Polnaszek B Kwabi-Addo LE Peterson M Ozen NM Greenberg S Ortega, et al. 2003 Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer Cancer Research 63 18 5754 5760 14522896
85. Z Song X Wu WC Powell RD Cardiff MB Cohen RT Tin, et al. 2002 Fibroblast growth factor 8 isoform B overexpression in prostate epithelium: a new mouse model for prostatic intraepithelial neoplasia Cancer Research 62 17 5096 5105 12208767
86. BA Foster A Evangelou JR Gingrich PJ Kaplan F DeMayo NM Greenberg 2002 Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice Differentiation 70 9-10 624 632 12492503
87. KW Freeman BE Welm RD Gangula JM Rosen M Ittmann NM Greenberg, et al. 2003 Inducible prostate intraepithelial neoplasia with reversible hyperplasia in conditional FGFR1-expressing mice Cancer Research 63 23 8256 8263 14678983
88. Z Culig A Hobisch MV Cronauer C Radmayr J Trapman A Hittmair, et al. 1994 Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor Cancer Research 54 20 5474 5478 7522959
89. J DiGiovanni DK Bol E Wilker L Beltran S Carbajal S Moats, et al. 2000 Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion Cancer Research 60 6 1561 1570 10749124
90. NA Bhowmick A Chytil D Plieth AE Gorska N Dumont S Shappell, et al. 2004 TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia Science 303 5659 848 851 14764882
91. N Konno-Takahashi T Takeuchi T Shimizu H Nishimatsu H Fukuhara T Kamijo, et al. 2003 Engineered IGF-I expression induces glandular enlargement in the murine prostate Journal of Endocrinology 177 3 389 398 12773119
92. J DiGiovanni K Kiguchi A Frijhoff E Wilker DK Bol L Beltran, et al. 2000 Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice Proceedings of the National Academy of Sciences of the United States of America 97 7 3455 3460 10737798 (Pubitemid 30183324)
93. JS Ross T Nazeer K Church C Amato H Figge MD Rifkin, et al. 1993 Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis Cancer 72 10 3020 3028 8106140
94. EJ Kuhn RA Kurnot IA Sesterhenn EH Chang JW Moul 1993 Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma Journal of Urology 150 5 Pt 1 1427 1433 8105108
95. KT Ow LA MH R Fisher J-L Yang J Mameghan S Andersen PJ Russell 1995 The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localised human prostatic adenocarcinoma Urologic Oncology 1 4 144 152
96. Z Li M Szabolcs JD Terwilliger A Efstratiadis 2006 Prostatic intraepithelial neoplasia and adenocarcinoma in mice expressing a probasin-Neu oncogenic transgene Carcinogenesis 27 5 1054 1067 16401639
97. A Elgavish PA Wood CA Pinkert IE Eltoum T Cartee J Wilbanks, et al. 2004 Transgenic mouse with human mutant p53 expression in the prostate epithelium Prostate 61 1 26 34 15287091
98. LA Maddison BW Sutherland RJ Barrios NM Greenberg 2004 Conditional deletion of Rb causes early stage prostate cancer Cancer Research 64 17 6018 6025 15342382
99. Y Wang SW Hayward AA Donjacour P Young T Jacks J Sage, et al. 2000 Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue Cancer Research 60 21 6008 6017 11085521
100. Z Zhou A Flesken-Nikitin DC Corney W Wang DW Goodrich P Roy-Burman, et al. 2006 Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer Cancer Research 66 16 7889 7898 16912162
101. C Bowen L Bubendorf HJ Voeller R Slack N Willi G Sauter, et al. 2000 Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression Cancer Research 60 21 6111 6115 11085535
102. SA Abdulkadir JA Magee TJ Peters Z Kaleem CK Naughton PA Humphrey, et al. 2002 Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia Molecular and Cellular Biology 22 5 1495 1503 11839815
103. R Bhatia-Gaur AA Donjacour PJ Sciavolino M Kim N Desai P Young, et al. 1999 Roles for Nkx3.1 in prostate development and cancer Genes and Development 13 8 966 977 10215624
104. A Scherl JF Li RD Cardiff N Schreiber-Agus 2004 Prostatic intraepithelial neoplasia and intestinal metaplasia in prostates of probasin-RAS transgenic mice Prostate 59 4 448 459 15065094
105. DH Castrillon RA DePinho 2001 Modeling prostate cancer in the mouse Advances in Cancer Research 82 187 204 11447763
106. PK Majumder JJ Yeh DJ George PG Febbo J Kum Q Xue, et al. 2003 Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model Proceedings of the National Academy of Sciences of the United States of America 100 13 7841 7846 12799464
107. A Di Cristofano B Pesce C Cordon-Cardo PP Pandolfi 1998 Pten is essential for embryonic development and tumour suppression Nature Genetics 19 4 348 355 9697695
108. K Podsypanina LH Ellenson A Nemes J Gu M Tamura KM Yamada, et al. 1999 Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems Proceedings of the National Academy of Sciences of the United States of America 96 4 1563 1568 9990064
109. B Kwabi-Addo D Giri K Schmidt K Podsypanina R Parsons N Greenberg, et al. 2001 Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression Proceedings of the National Academy of Sciences of the United States of America 98 20 11563 11568 11553783
110. S Wang J Gao Q Lei N Rozengurt C Pritchard J Jiao, et al. 2003 Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer Cancer Cell 4 3 209 221 14522255
111. C Voelkel-Johnson DJ Voeks NM Greenberg R Barrios F Maggouta DT Kurtz, et al. 2000 Genomic instability-based transgenic models of prostate cancer Carcinogenesis 21 8 1623 1627 10910968
112. RT Moon B Bowerman M Boutros N Perrimon 2002 The promise and perils of Wnt signaling through beta-catenin Science 296 5573 1644 1646 12040179
113. R Nusse HE Varmus 1992 Wnt genes Cell 69 7 1073 1087 1617723
114. G Chen N Shukeir A Potti K Sircar A Aprikian D Goltzman, et al. 2004 Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications Cancer 101 6 1345 1356 15316903
115. LG Horvath SM Henshall JG Kench DN Saunders CS Lee D Golovsky, et al. 2004 Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro Clinical Cancer Research 10 2 615 625 14760084
116. SM Phillips DG Morton SJ Lee DM Wallace JP Neoptolemos 1994 Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer British Journal of Urology 73 4 390 395 7911059
117. DR Chesire CM Ewing J Sauvageot GS Bova WB Isaacs 2000 Detection and analysis of beta-catenin mutations in prostate cancer Prostate 45 4 323 334 11102958
118. KJ Bruxvoort HM Charbonneau TA Giambernardi JC Goolsby CN Qian CR Zylstra, et al. 2007 Inactivation of Apc in the mouse prostate causes prostate carcinoma Cancer Research 67 6 2490 2496 17363566
119. NE Sharpless RA DePinho 1999 The INK4A/ARF locus and its two gene products Current Opinion in Genetics and Development 9 1 22 30 10072356
120. MJ You DH Castrillon BC Bastian RC O'Hagan MW Bosenberg R Parsons, et al. 2002 Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice Proceedings of the National Academy of Sciences of the United States of America 99 3 1455 1460 11818530
121. A Di Cristofano M De Acetis A Koff C Cordon-Cardo PP Pandolfi 2001 Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse Nature Genetics 27 2 222 224 11175795
122. MJ Kim RD Cardiff N Desai WA Banach-Petrosky R Parsons MM Shen, et al. 2002 Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis Proceedings of the National Academy of Sciences of the United States of America 99 5 2884 2889 11854455
123. C Abate-Shen WA Banach-Petrosky X Sun KD Economides N Desai JP Gregg, et al. 2003 Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases Cancer Research 63 14 3886 3890 12873978
124. ML Chen PZ Xu XD Peng WS Chen G Guzman X Yang, et al. 2006 The deficiency of Akt1 is sufficient to suppress tumor development in Pten+/- mice Genes and Development 20 12 1569 1574 16778075
125. C Zhong G Saribekyan CP Liao MB Cohen P Roy-Burman 2006 Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis Cancer Research 66 4 2188 2194 16489020
126. Z Chen LC Trotman D Shaffer HK Lin ZA Dotan M Niki, et al. 2005 Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis Nature 436 7051 725 730 16079851
127. SA Tomlins R Mehra DR Rhodes LR Smith D Roulston BE Helgeson, et al. 2006 TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer Cancer Research 66 7 3396 3400 16585160
128. SA Tomlins DR Rhodes S Perner SM Dhanasekaran R Mehra XW Sun, et al. 2005 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 5748 644 648 16254181
129. F Demichelis K Fall S Perner O Andren F Schmidt SR Setlur, et al. 2007 TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort Oncogene 26 31 4596 4599 17237811
130. S Perner MA Rubin 2008 A variant TMPRSS2 isoform and ERG fusion product in prostate cancer with implications for molecular diagnosis Modern Pathology 21 8 1056 18654591 author reply 1056-1057
131. S Perner F Demichelis R Beroukhim FH Schmidt JM Mosquera S Setlur, et al. 2006 TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer Cancer Research 66 17 8337 8341 16951139
132. SA Tomlins B Laxman S Varambally X Cao J Yu BE Helgeson, et al. 2008 Role of the TMPRSS2-ERG gene fusion in prostate cancer Neoplasia 10 2 177 188 18283340
133. BS Carver J Tran A Gopalan Z Chen S Shaikh A Carracedo, et al. 2009 Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate Nature Genetics 41 5 619 624 19396168
134. NP McCabe M Madajka A Vasanji TV Byzova 2008 Intraosseous injection of RM1 murine prostate cancer cells promotes rapid osteolysis and periosteal bone deposition Clinical & Experimental Metastasis 25 5 581 590
135. CA Power H Pwint J Chan J Cho Y Yu W Walsh PJ Russell 2009 A novel model of bone-metastatic prostate cancer in immunocompetent mice Prostate 69 15 1613 1623 19585491
136. S Gupta 2004 Prostate cancer chemoprevention: models, limitations and potential (Review) International Journal of Oncology 25 4 1133 1148 15375566
137. WJ Wechter DD Leipold ED Murray Jr D Quiggle JD McCracken RS Barrios, et al. 2000 E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse Cancer Research 60 8 2203 2208 10786685
138. S Gupta VM Adhami M Subbarayan GT MacLennan JS Lewin UO Hafeli, et al. 2004 Suppression of prostate carcinogenesis by dietary supplementation of celecoxib in transgenic adenocarcinoma of the mouse prostate model Cancer Research 64 9 3334 3343 15126378
139. BA Narayanan NK Narayanan B Pittman BS Reddy 2004 Regression of mouse prostatic intraepithelial neoplasia by nonsteroidal anti-inflammatory drugs in the transgenic adenocarcinoma mouse prostate model Clinical Cancer Research 10 22 7727 7737 15570007
140. MH Wang ME Grossmann CY Young 2004 Forced expression of heat-shock protein 70 increases the secretion of Hsp70 and provides protection against tumour growth British Journal of Cancer 90 4 926 931 14970875
141. M Saleem VM Adhami IA Siddiqui H Mukhtar 2003 Tea beverage in chemoprevention of prostate cancer: a mini-review Nutrition and Cancer 47 1 13 23 14769533 (Pubitemid 38250431)
142. VM Adhami N Ahmad H Mukhtar 2003 Molecular targets for green tea in prostate cancer prevention Journal of Nutrition 133 7 Suppl 2417S 2424S 12840218
143. S Gupta N Ahmad SR Marengo GT MacLennan NM Greenberg H Mukhtar 2000 Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice Cancer Research 60 18 5125 5133 11016639
144. S Raghow E Kuliyev M Steakley N Greenberg MS Steiner 2000 Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model Cancer Research 60 15 4093 4097 10945615 (Pubitemid 30636590)
145. MC Bosland 1999 Use of animal models in defining efficacy of chemoprevention agents against prostate cancer European Urology 35 5-6 459 463 10325505
146. A Caporali P Davalli S Astancolle D D'Arca M Brausi S Bettuzzi, et al. 2004 The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression Carcinogenesis 25 11 2217 2224 15358631
147. X Lin JR Gingrich W Bao J Li ZA Haroon W Demark-Wahnefried 2002 Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice Urology 60 5 919 924 12429338
148. R Mentor-Marcel CA Lamartiniere IA Eltoum NM Greenberg A Elgavish 2005 Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP) Journal of Nutrition 135 5 989 995 15867270
149. AW Suttie GE Dinse A Nyska GJ Moser TL Goldsworthy RR Maronpot 2005 An investigation of the effects of late-onset dietary restriction on prostate cancer development in the TRAMP mouse Toxicologic Pathology 33 3 386 397 15805078
150. WJ Huss L Lai RJ Barrios KK Hirschi NM Greenberg 2004 Retinoic acid slows progression and promotes apoptosis of spontaneous prostate cancer Prostate 61 2 142 152 15305337
151. AP Kumar S Bhaskaran M Ganapathy K Crosby MD Davis P Kochunov, et al. 2007 Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract Clinical Cancer Research 13 9 2784 2794 17473212
152. PK Majumder PG Febbo R Bikoff R Berger Q Xue LM McMahon, et al. 2004 mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways Nature Medicine 10 6 594 601 15156201
153. E Cheung P Wadhera T Dorff J Pinski 2008 Diet and prostate cancer risk reduction Expert Review of Anticancer Therapy 8 1 43 50 18095882
154. R Medeiros A Morais A Vasconcelos S Costa D Pinto J Oliveira, et al. 2002 The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population Journal of Human Genetics 47 8 413 418 12181642
155. W Banach-Petrosky X Ouyang H Gao K Nader Y Ji N Suh, et al. 2006 Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice Clinical Cancer Research 12 19 5895 5901 17020998
156. CM Perez-Stable GG Schwartz A Farinas M Finegold L Binderup GA Howard, et al. 2002 The G gamma/T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089 Cancer Epidemiology, Biomarkers and Prevention 11 6 555 563 12050097
157. RE Patterson E White AR Kristal ML Neuhouser JD Potter 1997 Vitamin supplements and cancer risk: the epidemiologic evidence Cancer Causes and Control 8 5 786 802 9328202
158. VA Kirsh RB Hayes ST Mayne N Chatterjee AF Subar LB Dixon, et al. 2006 Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk Journal of the National Cancer Institute 98 4 245 254 16478743
159. Y Yin J Ni M Chen MA DiMaggio Y Guo S Yeh 2007 The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3 Clinical Cancer Research 13 7 2271 2280 17404112
160. JM Chan MJ Stampfer J Ma P Gann JM Gaziano M Pollak, et al. 2002 Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer Journal of the National Cancer Institute 94 14 1099 1106 12122101
161. S Gupta K Hastak N Ahmad JS Lewin H Mukhtar 2001 Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols Proceedings of the National Academy of Sciences of the United States of America 98 18 10350 10355 11504910
162. AA Hurwitz BA Foster ED Kwon T Truong EM Choi NM Greenberg, et al. 2000 Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade Cancer Research 60 9 2444 2448 10811122
163. Z Liu IE Eltoum B Guo BH Beck GA Cloud RD Lopez 2008 Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancer Journal of Immunology 180 9 6044 6053
164. JY Adams M Johnson M Sato F Berger SS Gambhir M Carey, et al. 2002 Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging Nature Medicine 8 8 891 897 12134144
165. CD Scatena MA Hepner YA Oei JM Dusich SF Yu T Purchio, et al. 2004 Imaging of bioluminescent LNCaP-luc-M6 tumors: a new animal model for the study of metastatic human prostate cancer Prostate 59 3 292 303 15042605
166. K Ellwood-Yen J Wongvipat C Sawyers 2006 Transgenic mouse model for rapid pharmacodynamic evaluation of antiandrogens Cancer Research 66 21 10513 10516 17079473
167. CL Hsieh Z Xie ZY Liu JE Green WD Martin MW Datta, et al. 2005 A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals Journal of Molecular Endocrinology 35 2 293 304 16216910
168. SK Lyons E Lim AO Clermont J Dusich L Zhu KD Campbell, et al. 2006 Noninvasive bioluminescence imaging of normal and spontaneously transformed prostate tissue in mice Cancer Research 66 9 4701 4707 16651422
169. X Xie Z Luo KM Slawin DM Spencer 2004 The EZC-prostate model: noninvasive prostate imaging in living mice Molecular Endocrinology 18 3 722 732 14684850
170. CP Liao C Zhong G Saribekyan J Bading R Park PS Conti, et al. 2007 Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence Cancer Research 67 15 7525 7533 17671224
171. JW Xuan M Bygrave H Jiang F Valiyeva J Dunmore-Buyze DW Holdsworth, et al. 2007 Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound Cancer Research 67 6 2830 2839 17363606
172. A Degrassi M Russo E Scanziani A Giusti R Ceruti G Texido, et al. 2007 Magnetic resonance imaging and histopathological characterization of prostate tumors in TRAMP mice as model for pre-clinical trials Prostate 67 4 396 404 17187397
173. MJ Paulus SS Gleason ME Easterly CJ Foltz 2001 A review of high-resolution X-ray computed tomography and other imaging modalities for small animal research Lab Animal (NY) 30 3 36 45
174. J Jonkers A Berns 2002 Conditional mouse models of sporadic cancer Nature Reviews. Cancer 2 4 251 265 12001987
175. A Bex M Vooijs S Horenblas A Berns 2002 Controlling gene expression in the urothelium using transgenic mice with inducible bladder specific Cre-lox recombination Journal of Urology 168 6 2641 2644 12442001
176. SF Winter AB Cooper NM Greenberg 2003 Models of metastatic prostate cancer: a transgenic perspective Prostate Cancer and Prostatic Diseases 6 3 204 211 12970722
177. TO Kirby A Rivera D Rein M Wang I Ulasov M Breidenbach, et al. 2004 A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity Clinical Cancer Research 10 24 8697 8703 15623655
178. CL Krumdieck JE dos Santos KJ Ho 1980 A new instrument for the rapid preparation of tissue slices Analytical Biochemistry 104 1 118 123 6770714
179. P Olinga IH Hof MT Merema M Smit MH de Jager PJ Swart, et al. 2001 The applicability of rat and human liver slices to the study of mechanisms of hepatic drug uptake Journal of Pharmacological and Toxicological Methods 45 1 55 63 11489665
180. MY Gabril T Onita PG Ji H Sakai FL Chan J Koropatnick, et al. 2002 Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model Gene Therapy 9 23 1589 1599 12424611
181. X Zhang MW Chen A Ng PY Ng C Lee M Rubin, et al. 1997 Abnormal prostate development in C3(1)-bcl-2 transgenic mice Prostate 32 1 16 26 9207953
182. EM Bruckheimer S Brisbay DJ Johnson JR Gingrich N Greenberg TJ McDonnell 2000 Bcl-2 accelerates multistep prostate carcinogenesis in vivo Oncogene 19 46 5251 5258 11077442
183. J Wang IE Eltoum CA Lamartiniere 2007 Genistein chemoprevention of prostate cancer in TRAMP mice Journal of Carcinogenesis 6 3 17367528
184. R Mentor-Marcel CA Lamartiniere IE Eltoum NM Greenberg A Elgavish 2001 Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP) Cancer Research 61 18 6777 6782 11559550
185. CE Harper BB Patel J Wang A Arabshahi IA Eltoum CA Lamartiniere 2007 Resveratrol suppresses prostate cancer progression in transgenic mice Carcinogenesis 28 9 1946 1953 17675339
186. UP Kelavkar W Glasgow SJ Olson BA Foster SB Shappell 2004 Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice Neoplasia 6 6 821 830 15720809
187. A Barve TO Khor X Hao YS Keum CS Yang B Reddy, et al. 2008 Murine prostate cancer inhibition by dietary phytochemicals-curcumin and phenyethylisothiocyanate Pharmaceutical Research 25 9 2181 2189 18437538
188. TL Cha L Qiu CT Chen Y Wen MC Hung 2005 Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth Cancer Research 65 6 2287 2295 15781642
189. S Raghow MZ Hooshdaran S Katiyar MS Steiner 2002 Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model Cancer Research 62 5 1370 1376 11888907
190. AM Sargeant RD Klein RC Rengel SK Clinton SK Kulp Y Kashida, et al. 2007 Chemopreventive and bioenergetic signaling effects of PDK1/Akt pathway inhibition in a transgenic mouse model of prostate cancer Toxicologic Pathology 35 4 549 561 17562488
191. A Tehranian DW Morris BH Min DJ Bird RD Cardiff PA Barry 1996 Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene American Journal of Pathology 149 4 1177 1191 8863667
192. L Hennighausen R McKnight T Burdon M Baik RJ Wall GH Smith 1994 Whey acidic protein extrinsically expressed from the mouse mammary tumor virus long terminal repeat results in hyperplasia of the coagulation gland epithelium and impaired mammary development Cell Growth and Differentiation 5 6 607 613 7522033
193. O Klezovitch J Chevillet J Mirosevich RL Roberts RJ Matusik V Vasioukhin 2004 Hepsin promotes prostate cancer progression and metastasis Cancer Cell 6 2 185 195 15324701
194. SA Backman D Ghazarian K So O Sanchez KU Wagner L Hennighausen, et al. 2004 Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten Proceedings of the National Academy of Sciences of the United States of America 101 6 1725 1730 14747659